Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 19.86%94.92B | 11.01%278.8B | 8.52%79.19B | 21.29%251.14B | 0.11%72.97B | -2.38%207.06B | -1.15%72.89B | 18.11%212.11B | 63.80%73.74B | 21.21%179.59B |
| Operating income | 19.86%94.92B | 11.01%278.8B | 8.52%79.19B | 21.29%251.14B | 0.11%72.97B | -2.38%207.06B | -1.15%72.89B | 18.11%212.11B | 63.80%73.74B | 21.21%179.59B |
| Cost of sales | -17.16%-72.14B | -16.22%-218.47B | -13.50%-61.57B | -23.04%-187.98B | -1.86%-54.25B | 1.38%-152.77B | -5.18%-53.26B | -24.75%-154.91B | -69.22%-50.63B | -34.93%-124.17B |
| Operating expenses | -17.16%-72.14B | -16.22%-218.47B | -13.50%-61.57B | -23.04%-187.98B | -1.86%-54.25B | 1.38%-152.77B | -5.18%-53.26B | -24.75%-154.91B | -69.22%-50.63B | -34.93%-124.17B |
| Gross profit | 29.32%22.78B | -4.48%60.33B | -5.89%17.62B | 16.34%63.16B | -4.65%18.72B | -5.09%54.29B | -15.03%19.64B | 3.22%57.2B | 53.06%23.11B | -1.29%55.42B |
| Selling expenses | -0.55%-2.74B | -6.75%-7.79B | -2.48%-2.73B | -23.87%-7.3B | -32.84%-2.66B | 3.27%-5.89B | 20.91%-2B | -13.86%-6.09B | -35.69%-2.53B | -3.66%-5.35B |
| Administrative expenses | -9.46%-2.04B | 10.15%-6B | 18.15%-1.86B | -24.01%-6.68B | -2.93%-2.28B | 8.28%-5.39B | 8.09%-2.21B | -15.42%-5.87B | -38.99%-2.41B | 11.97%-5.09B |
| Revaluation surplus | -29.07%2.58B | -3.23%7.79B | -2.51%3.64B | 15.28%8.05B | 56.70%3.74B | -10.88%6.98B | -50.11%2.39B | -12.37%7.84B | 11.49%4.78B | -16.89%8.94B |
| -Changes in the fair value of investment property | -27.97%2.56B | -4.61%7.63B | -4.92%3.55B | 14.66%8B | 56.81%3.73B | -10.48%6.98B | -49.79%2.38B | -12.26%7.79B | 11.44%4.74B | -17.22%8.88B |
| -Changes in the fair value of other assets | -70.28%28.27M | 213.22%159.77M | 1,660.21%95.12M | 697.03%51.01M | 5.16%5.4M | -85.02%6.4M | -87.60%5.14M | -28.68%42.71M | 17.18%41.43M | 99.89%59.89M |
| Special items of operating profit | -53.57%1.58B | -22.09%6.69B | -23.80%3.41B | 175.90%8.59B | 265.38%4.47B | -29.16%3.11B | -30.72%1.22B | -3.13%4.39B | 8.23%1.77B | 58.72%4.54B |
| Operating profit | 10.40%22.17B | -7.29%61.02B | -8.70%20.08B | 23.94%65.82B | 15.58%21.99B | -7.58%53.11B | -23.01%19.03B | -1.69%57.47B | 41.89%24.72B | -0.61%58.46B |
| Financing cost | -72.35%-1.52B | -82.45%-3.18B | 1.08%-882.73M | -2.61%-1.74B | 1.35%-892.36M | -21.64%-1.7B | 4.09%-904.54M | -8.81%-1.4B | -58.15%-943.14M | 7.59%-1.28B |
| Share of profits of associates | -77.38%60.64M | 188.24%388.84M | -65.96%268.09M | -171.45%-440.63M | 36.98%787.59M | -58.58%616.71M | 69.24%574.95M | 35.38%1.49B | -48.94%339.73M | -36.83%1.1B |
| Share of profit from joint venture company | 2.87%1.19B | -100.02%-604K | -0.52%1.16B | -19.63%2.8B | 5.30%1.16B | 24.09%3.48B | 54.30%1.1B | 47.81%2.81B | -55.71%715.61M | -3.89%1.9B |
| Earning before tax | 6.19%21.9B | -12.36%58.23B | -10.54%20.62B | 19.69%66.44B | 16.40%23.05B | -8.04%55.51B | -20.24%19.81B | 0.32%60.37B | 29.96%24.83B | -1.59%60.17B |
| Tax | 11.39%-7.21B | 15.74%-24.55B | -16.38%-8.14B | -25.91%-29.13B | 1.79%-6.99B | -0.74%-23.14B | 22.94%-7.12B | 11.93%-22.97B | -52.98%-9.24B | 2.25%-26.08B |
| After-tax profit from continuing operations | 17.64%14.69B | -9.72%33.68B | -22.26%12.48B | 15.24%37.3B | 26.61%16.06B | -13.44%32.37B | -18.64%12.68B | 9.70%37.4B | 19.32%15.59B | -1.08%34.09B |
| Earning after tax | 17.64%14.69B | -9.72%33.68B | -22.26%12.48B | 15.24%37.3B | 26.61%16.06B | -13.44%32.37B | -18.64%12.68B | 9.70%37.4B | 19.32%15.59B | -1.08%34.09B |
| Minority profit | 24.10%2.81B | 36.42%8.1B | -2.58%2.26B | 38.82%5.94B | 11.56%2.32B | -14.34%4.28B | -15.56%2.08B | 23.02%4.99B | 67.44%2.46B | -24.68%4.06B |
| Special items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.74%220.57M |
| Profit attributable to shareholders | 16.21%11.88B | -18.45%25.58B | -25.59%10.22B | 11.65%31.37B | 29.56%13.74B | -13.30%28.09B | -19.22%10.6B | 8.69%32.4B | 15.41%13.13B | 3.57%29.81B |
| Basic earnings per share | 16.78%1.67 | -18.41%3.59 | -25.91%1.43 | 11.68%4.4 | 29.53%1.93 | -13.22%3.94 | -19.02%1.49 | 8.61%4.54 | 15.72%1.84 | 1.21%4.18 |
| Diluted earnings per share | 16.78%1.67 | -18.41%3.59 | -25.91%1.43 | 11.68%4.4 | 29.53%1.93 | 3.94 | 1.49 | |||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.